Anthrax

Indian company says it is developing new vaccine

Published in Vaccine Weekly, September 10th, 2003

An Indian company says it is conducting trials for an anthrax vaccine that will be safer and cheaper than the vaccine currently used around the world and that it hopes to begin selling by March 2004.

"We have completed 75% of trials on animals. We will be starting human trials in December," said Anil Chawla, head of research and development at Panacea Biotech, a New Delhi-based biotechnology firm.

Ever since the U.S. Food and Drug Administration approved Anthrax Vaccine Adsorbed - the vaccine currently used in the United States and other countries - 30 years ago, scientists have been trying to improve on it.

The old preparation...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2003-09-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry